1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Herrador Z, Gherasim A, López-Vélez R, Benito A.

    Listeriosis in Spain based on hospitalisation records, 1997 to 2015: need for greater awareness.

    Eurosurveillance . 24(21): 22-31. Nº de citas: 35

    [doi:10.2807/1560-7917.ES.2019.24.21.1800271]

  • Salvador F, Treviño B, Chamorro-Tojeiro S, Sánchez-Montalvá A, Herrero-Martínez JM, Rodríguez-Guardado A, Serre-Delcor N, Torrús D, Goikoetxea J, Zubero Z, Velasco M, Sulleiro E, Molina I, López-Vélez R, Pérez-Molina JA, on behalf the +REDIVI Collaborative Network.

    Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017).

    PLOS NEGLECTED TROPICAL DISEASES . 13(5): . Nº de citas: 30

    [doi:10.1371/journal.pntd.0007399]

  • Soto-Castillo JJ, Fortún-Abete J, Soria-Rivas A.

    Black ulcer in leg.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 37(5): 344-346.

    [doi:10.1016/j.eimc.2018.09.005]

  • Pintado V, Pazos R, Jiménez-Mejías ME, Rodríguez-Guardado A, Díaz-Pollán B, Cabellos C, García-Lechuz JM, Lora-Tamayo J, Domingo P, Muñez E, Domingo D, González-Romo F, Lepe-Jiménez JA, Rodríguez-Lucas C, Gil A, Pelegrín I, Chaves F, Pomar V, Ramos A, Alarcón T, Pérez-Cecilia E.

    Staphylococcus aureus meningitis in adults: A comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strains.

    Journal of Hospital Infection . 102(1): 108-115. Nº de citas: 15

    [doi:10.1016/j.jhin.2018.11.008]

  • Ruiz-Mateos E, Ruiz-León MJ, Tarancón-Díez L, Gutiérrez C, Dronda F, Domínguez-Molina B, Pérez-Elías MJ, Moreno A, Leal M, Moreno S, Vallejo A.

    High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.

    VIRUS RESEARCH . 264: 40-44. Nº de citas: 6

    [doi:10.1016/j.virusres.2019.02.007]

  • López-Huertas MR, Palladino C, Garrido-Arquero M, Esteban-Cartelle B, Sánchez-Carrillo M, Martínez-Román P, Martín-Carbonero L, Ryan P, Domínguez-Domínguez L, Santos IL, Moral SF, Benito JM, Rallón N, Alcamí J, Resino S, Fernández-Rodríguez A, Coiras M, Briz V, Multidisciplinary Group of viral coinfection HIV/Hepatitis (COVIHEP).

    HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study.

    SCIENTIFIC REPORTS . 9(1): 5606-5606. Nº de citas: 24

    [doi:10.1038/s41598-019-41788-9]

  • Sánchez-Conde M, Rodriguez-Centeno J, Dronda F, López JC, Jiménez Z, Berenguer J, Pérez-Elías MJ, Moreno S, Rodés B, Brañas F.

    Frailty phenotype: a clinical marker of age acceleration in the older HIV-infected population.

    Epigenomics . 11(5): 501-509. Nº de citas: 17

    [doi:10.2217/epi-2018-0130]

  • Fontecha M, Monsalvo M, Rodriguez-Sagrado MA, Vivancos MJ, Moreno A, Casado JL.

    Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir.

    Infectious Diseases . 51(4): 1-6. Nº de citas: 3

    [doi:10.1080/23744235.2018.1554908]

  • Moreno S, Perno CF, Mallon PW, Behrens G, Corbeau P, Routy JP, Darcis G.

    Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?

    HIV MEDICINE . 20 Suppl 4: 2-12. Nº de citas: 67

    [doi:10.1111/hiv.12716]

  • Venanzi E, Martín-Dávila P, López J, Maiz L, de la Pedrosa EG, Gioia F, Escudero R, Filigheddu E, Moreno S, Fortún J.

    Aerosolized Lipid Amphotericin B for Complementary Therapy and/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience.

    MYCOPATHOLOGIA . 184(2): 239-250. Nº de citas: 9

    [doi:10.1007/s11046-019-00331-0]

  • Casado JL, Monsalvo M, Fontecha M, Vizcarra P, Rodriguez MA, Vivancos MJ, Moreno S.

    Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting.

    HIV Research & Clinical Practice . 20(2): 64-72. Nº de citas: 13

    [doi:10.1080/15284336.2019.1628460]

  • Vivancos, Maria J., Martinez-Sanz, Javier, Moreno, Santiago.

    HIV infection epidemiology: a change of scenery

    European Geriatric Medicine . 10(2): 169-174. Nº de citas: 4

    [doi:10.1007/s41999-018-0147-y]

  • Sanchez-Conde, Matilde, Diaz-Alvarez, Jorge, Dronda, Fernando, Branas, Fatima.

    Why are people with HIV considered "older adults" in their fifties?

    European Geriatric Medicine . 10(2): 183-188. Nº de citas: 26

    [doi:10.1007/s41999-018-0148-x]

  • Milic, Jovana, Russwurm, Magdalena, Cerezales Calvino, Ana, Branas, Fatima, Sanchez-Conde, Matilde, Guaraldi, Giovanni.

    European cohorts of older HIV adults: POPPY, AGE(h)IV, GEPPO, COBRA and FUNCFRAIL

    European Geriatric Medicine . 10(2): 247-257. Nº de citas: 17

    [doi:10.1007/s41999-019-00170-8]

  • Rodríguez-Muñoz J, Moreno S.

    Strategies for the cure of HIV infection.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 37(4): 265-273. Nº de citas: 10

    [doi:10.1016/j.eimc.2018.01.007]

  • Ercibengoa M, Goenaga MA, Ardanuy C, Grau I, García-de-la-Maria C, Almela M, Miro JM, Navas E, Fariñas MC, de Alegría CR, de la Torre J, Fernández F, Marín M, Muñoz P, Orden B, Oteo JA, García-Álvarez L, de Alarcón A, Jiménez JAL, Marimón JM.

    Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditis.

    BMC INFECTIOUS DISEASES . 19(1): 291-291. Nº de citas: 7

    [doi:10.1186/s12879-019-3914-6]

  • Gutiérrez C, Lopez-Abente J, Pérez-Fernández V, Prieto-Sánchez A, Correa-Rocha R, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M.

    Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients.

    Plos One . 14(3): . Nº de citas: 10

    [doi:10.1371/journal.pone.0213744]

  • Mitsuwan, Watcharapong, Jimenez-Munguia, Irene, Visutthi, Monton, Sianglum, Wipawadee, Jover, A., Barcenilla, F., Garcia, M., Pujol, M., Gasch, O., Dominguez, M. A., Camoez, M., Duenas, C., Ojeda, E., Martinez, J. A., Marco, F., Chaves, F., Lagarde, M., Lopez-Medrano, F., Montejo, J. M., Bereciertua, E., Hernandez, J. L., von Wichmann, M. A., Goenaga, A., Garcia-Arenzana, J. M., Padilla, B., Padilla, C., Cercenado, E., Garcia-Prado, G., Tapiol, J., Horcajada, J. P., Montero, M., Salvado, M., Arnaiz, A., Fernandez, C., Calbo, E., Xercavins, M., Granados, A., Fontanals, D., Pintado, V, Loza, E., Torre-Cisneros, J., Lara, R., Rodriguez-Lopez, F., Natera, C., Blanco, J. R., Olarte, I, Benito, N., Mirelis, B., Murillas, J., Ruiz de Gopegui, E., Espejo, H., Morera, M. A., Rodriguez-Bano, J., Lopez-Cortes, L. E., Pascual, A., Martin, C., Lepe, J. A., Molina, J., Sorde, R., Almirante, B., Larrosa, N., Rodriguez-Ortega, Manuel J., Voravuthikunchai, Supayang P..

    Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles

    MICROBIAL PATHOGENESIS . 128: 112-118. Nº de citas: 16

    [doi:10.1016/j.micpath.2018.12.019]